Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOARS-B: Oxytocin in Autism
NCT01944046Phase 2Completed
- Start
- Aug 2014
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD). Started Aug 2014; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01944046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944046.